Tg Therapeutics Inc (TGTX)

Other Income/Expenses (Net)

-$11.44M

Quarterly · Period ending: · USD

TGTX logo

TGTX Other Income/Expenses (Net)

Latest reported-$11.44M
TGTX Quarterly Other Income/Expenses (Net) (-$100.00K → -$11.44M)
High-resolution chart · PNG

TGTX other income/expenses (net) history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Tg Therapeutics Inc Other Income/Expenses (Net) — Quarterly (USD)
Period endingOther Income/Expenses (Net) (USD)
-11,440,000
-14,432,000
-5,401,000
-3,456,000
-3,923,000
-3,154,000
-4,496,000
-8,166,000
-2,265,000
-1,408,000
-1,541,000
-854,000
-2,936,000
-2,240,000
-932,000
-855,000
-1,569,000
-2,141,000
-391,000
-509,000
-1,004,000
-1,426,000
-1,436,000
-1,441,000
-2,039,000
-871,000
-1,611,000
-1,069,000
-669,000
-467,000
290,000
377,000
203,000
48,000
174,964
49,348
71,916
-61,509
353,915
94,444
124,381
143,494
28,189
169,668
8,397
25,116
-75,305
-11,823
-30,933
57,876
-485,686
91,222
44,213
40,430
3,690,589
4,025
530,771
-11,184
-1,456,036
-521,624
0
0
825,153
556,878
525,091
-942,261
-64,128
-20,449
0
-204,508
-2,269
-10,758
45,054
54,657
1,918,756
37,600
29,608
0
-1,492
68,026
86,247
99,196
-9,117,750
49,137
37,142
2,933
1,791,905
47,614
125,110
27,163
0
-2,462,108
0
0
0
0
0
0
558,193
-37,309
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.